Exact Mass: 477.18211360000004
Exact Mass Matches: 477.18211360000004
Found 287 metabolites which its exact mass value is equals to given mass value 477.18211360000004
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Batimastat
Pralatrexate
O-methyl siphonazole|siphonazole B
C26H27N3O6 (477.18997620000005)
7-hydroxy-1-(3,4-dihydroxy)-N2,N3-bis(4-hydroxyphenethyl)-6,8-dimethoxy-1,2-dihydronaphthalene-2,3-dicarboxamide
C27H27NO7 (477.17874320000004)
Pralatrexate
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BA - Folic acid analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor
Ala Asp Ser Trp
Ala Asp Trp Ser
Ala Glu Met Gln
Ala Glu Gln Met
Ala Met Glu Gln
Ala Met Gln Glu
Ala Gln Glu Met
Ala Gln Met Glu
Ala Ser Asp Trp
Ala Ser Trp Asp
Ala Trp Asp Ser
Ala Trp Ser Asp
Cys Cys Pro Arg
Cys Cys Arg Pro
Cys Asp Ile Gln
Cys Asp Leu Gln
Cys Asp Gln Ile
Cys Asp Gln Leu
Cys Glu Ile Asn
Cys Glu Leu Asn
Cys Glu Asn Ile
Cys Glu Asn Leu
Cys Glu Gln Val
Cys Glu Val Gln
Cys Ile Asp Gln
Cys Ile Glu Asn
Cys Ile Asn Glu
Cys Ile Gln Asp
Cys Leu Asp Gln
Cys Leu Glu Asn
Cys Leu Asn Glu
Cys Leu Gln Asp
Cys Asn Glu Ile
Cys Asn Glu Leu
Cys Asn Ile Glu
Cys Asn Leu Glu
Cys Pro Cys Arg
Cys Pro Arg Cys
Cys Gln Asp Ile
Cys Gln Asp Leu
Cys Gln Glu Val
Cys Gln Ile Asp
Cys Gln Leu Asp
Cys Gln Val Glu
Cys Arg Cys Pro
Cys Arg Pro Cys
Cys Val Glu Gln
Cys Val Gln Glu
Asp Ala Ser Trp
Asp Ala Trp Ser
Asp Cys Ile Gln
Asp Cys Leu Gln
Asp Cys Gln Ile
Asp Cys Gln Leu
Asp Gly Thr Trp
Asp Gly Trp Thr
Asp Ile Cys Gln
Asp Ile Gln Cys
Asp Leu Cys Gln
Asp Leu Gln Cys
Asp Met Asn Val
Asp Met Val Asn
Asp Asn Met Val
Asp Asn Val Met
Asp Gln Cys Ile
Asp Gln Cys Leu
Asp Gln Ile Cys
Asp Gln Leu Cys
Asp Ser Ala Trp
Asp Ser Trp Ala
Asp Thr Gly Trp
Asp Thr Trp Gly
Asp Val Met Asn
Asp Val Asn Met
Asp Trp Ala Ser
Asp Trp Gly Thr
Asp Trp Ser Ala
Asp Trp Thr Gly
Glu Ala Met Gln
Glu Ala Gln Met
Glu Cys Ile Asn
Glu Cys Leu Asn
Glu Cys Asn Ile
Glu Cys Asn Leu
Glu Cys Gln Val
Glu Cys Val Gln
Glu Gly Ser Trp
Glu Gly Trp Ser
Glu Ile Cys Asn
Glu Ile Asn Cys
Glu Leu Cys Asn
Glu Leu Asn Cys
Glu Met Ala Gln
Glu Met Gln Ala
Glu Asn Cys Ile
Glu Asn Cys Leu
Glu Asn Ile Cys
Glu Asn Leu Cys
Glu Gln Ala Met
Glu Gln Cys Val
Glu Gln Met Ala
Glu Gln Val Cys
Glu Ser Gly Trp
Glu Ser Trp Gly
Glu Val Cys Gln
Glu Val Gln Cys
Glu Trp Gly Ser
Glu Trp Ser Gly
Gly Asp Thr Trp
Gly Asp Trp Thr
Gly Glu Ser Trp
Gly Glu Trp Ser
Gly Ser Glu Trp
Gly Ser Trp Glu
Gly Thr Asp Trp
Gly Thr Trp Asp
3,5-Pyridinedicarboxylic acid, 2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-[methyl(phenylmethyl)amino]
C26H27N3O6 (477.18997620000005)
Gly Trp Asp Thr
Gly Trp Glu Ser
Gly Trp Ser Glu
Gly Trp Thr Asp
Ile Cys Asp Gln
Ile Cys Glu Asn
Ile Cys Asn Glu
Ile Cys Gln Asp
Ile Asp Cys Gln
Ile Asp Gln Cys
Ile Glu Cys Asn
Ile Glu Asn Cys
Ile Asn Cys Glu
Ile Asn Glu Cys
Ile Gln Cys Asp
Ile Gln Asp Cys
Leu Cys Asp Gln
Leu Cys Glu Asn
Leu Cys Asn Glu
Leu Cys Gln Asp
Leu Asp Cys Gln
Leu Asp Gln Cys
Leu Glu Cys Asn
Leu Glu Asn Cys
Leu Asn Cys Glu
Leu Asn Glu Cys
Leu Gln Cys Asp
Leu Gln Asp Cys
Met Ala Glu Gln
Met Ala Gln Glu
Met Asp Asn Val
Met Asp Val Asn
Met Glu Ala Gln
Met Glu Gln Ala
Met Asn Asp Val
Met Asn Val Asp
Met Gln Ala Glu
Met Gln Glu Ala
Met Val Asp Asn
Met Val Asn Asp
Asn Cys Glu Ile
Asn Cys Glu Leu
Asn Cys Ile Glu
Asn Cys Leu Glu
Asn Asp Met Val
Asn Asp Val Met
Asn Glu Cys Ile
Asn Glu Cys Leu
Asn Glu Ile Cys
Asn Glu Leu Cys
Asn Ile Cys Glu
Asn Ile Glu Cys
Asn Leu Cys Glu
Asn Leu Glu Cys
Asn Met Asp Val
Asn Met Val Asp
Asn Val Asp Met
Asn Val Met Asp
Pro Cys Cys Arg
Pro Cys Arg Cys
Pro Arg Cys Cys
Gln Ala Glu Met
Gln Ala Met Glu
Gln Cys Asp Ile
Gln Cys Asp Leu
Gln Cys Glu Val
Gln Cys Ile Asp
Gln Cys Leu Asp
Gln Cys Val Glu
Gln Asp Cys Ile
Gln Asp Cys Leu
Gln Asp Ile Cys
Gln Asp Leu Cys
Gln Glu Ala Met
Gln Glu Cys Val
Gln Glu Met Ala
Gln Glu Val Cys
Gln Ile Cys Asp
Gln Ile Asp Cys
Gln Leu Cys Asp
Gln Leu Asp Cys
Gln Met Ala Glu
Gln Met Glu Ala
Gln Val Cys Glu
Gln Val Glu Cys
Arg Cys Cys Pro
Arg Cys Pro Cys
Arg Pro Cys Cys
Ser Ala Asp Trp
Ser Ala Trp Asp
Ser Asp Ala Trp
Ser Asp Trp Ala
Ser Glu Gly Trp
Ser Glu Trp Gly
Ser Gly Glu Trp
Ser Gly Trp Glu
Ser Trp Ala Asp
Ser Trp Asp Ala
Ser Trp Glu Gly
Ser Trp Gly Glu
Thr Asp Gly Trp
Thr Asp Trp Gly
Thr Gly Asp Trp
Thr Gly Trp Asp
Thr Trp Asp Gly
Thr Trp Gly Asp
Val Cys Glu Gln
Val Cys Gln Glu
Val Asp Met Asn
Val Asp Asn Met
Val Glu Cys Gln
Val Glu Gln Cys
Val Met Asp Asn
Val Met Asn Asp
Val Asn Asp Met
Val Asn Met Asp
Val Gln Cys Glu
Val Gln Glu Cys
Trp Ala Asp Ser
Trp Ala Ser Asp
Trp Asp Ala Ser
Trp Asp Gly Thr
Trp Asp Ser Ala
Trp Asp Thr Gly
Trp Glu Gly Ser
Trp Glu Ser Gly
Trp Gly Asp Thr
Trp Gly Glu Ser
Trp Gly Ser Glu
Trp Gly Thr Asp
Trp Ser Ala Asp
Trp Ser Asp Ala
Trp Ser Glu Gly
Trp Ser Gly Glu
Trp Thr Asp Gly
Trp Thr Gly Asp
CAY10485
C27H27NO7 (477.17874320000004)
Batimastat
C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C1970 - Matrix Metalloproteinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors D000970 - Antineoplastic Agents
(3S)-3-[[[(2S)-1-[(2S)-2-[[(4-amino-3-chlorophenyl)-oxomethyl]amino]-3,3-dimethyl-1-oxobutyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-cyanopropanoic acid
C22H28ClN5O5 (477.17788680000007)
2-[2-Oxo-2-[4-(4-phenyl-1-phthalazinyl)-1-piperazinyl]ethyl]isoindole-1,3-dione
C28H23N5O3 (477.18008080000004)
N-butan-2-yl-2-[[3-(1,5-dimethyl-3-oxo-2-phenyl-4-pyrazolyl)-4-oxo-2-quinazolinyl]thio]acetamide
C25H27N5O3S (477.18345120000004)
4-Nitrophenyl 4-(bis(4-methoxyphenyl)methyl)piperazine-1-carboxylate
C26H27N3O6 (477.18997620000005)
(1R,9S,10S,11S)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-6-oxo-5-pyridin-4-yl-12-(1,3-thiazol-2-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C25H27N5O3S (477.18345120000004)
(1S,9R,10R,11R)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-6-oxo-5-pyridin-4-yl-12-(1,3-thiazol-2-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C25H27N5O3S (477.18345120000004)
Butyl 4,7-DI(para-ethoxyphenyl)-1,2,5-thiadiazolo(3,4-C)pyridine-6-carboxylate
C26H27N3O4S (477.1722182000001)
CP-346086
CP-346086 is a potent and orally active microsomal triglyceride transfer protein (MTP) inhibitor, with an IC50 of 2.0 nM for human and rodent MTP. CP-346086 can lower plasma cholesterol and triglycerides in vivo[1].
(2r,3s,4s,5r,6r)-5-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-6-{[5-hydroxy-4-(methoxymethyl)-6-methylpyridin-3-yl]methoxy}-2-(hydroxymethyl)oxane-3,4-diol
(2e)-3-[(2r,3r)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-n-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidic acid
C27H27NO7 (477.17874320000004)
2,3-dihydroxy-10,12-dimethoxy-6-(4-methoxyphenyl)-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboximidic acid
C27H27NO7 (477.17874320000004)
(2s,3r,4r,5s,6r)-2,3-dihydroxy-10,12-dimethoxy-6-(4-methoxyphenyl)-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboximidic acid
C27H27NO7 (477.17874320000004)
n-[2,4-bis({4-[(methoxycarbonyl)amino]phenyl}methyl)phenyl]methoxycarboximidic acid
C26H27N3O6 (477.18997620000005)
3-[(2r,3r)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-n-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidic acid
C27H27NO7 (477.17874320000004)
(2z)-3-[(2r,3r)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-n-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidic acid
C27H27NO7 (477.17874320000004)
(2s,3s,4s,5s,6r)-2,3-dihydroxy-10,12-dimethoxy-6-(4-methoxyphenyl)-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboximidic acid
C27H27NO7 (477.17874320000004)
1,6,8-trihydroxy-5-[(2r,4r,5s,6r)-5-(hydroxymethyl)-6-methyl-4-(methylamino)oxan-2-yl]-3-methyltetraphene-7,12-dione
C27H27NO7 (477.17874320000004)
2-(2-{2-[2-(3,4-dimethoxyphenyl)ethenyl]-5-methyl-1,3-oxazol-4-yl}-2-oxoethyl)-5-methyl-n-(penta-2,4-dien-1-yl)-1,3-oxazole-4-carboximidic acid
C26H27N3O6 (477.18997620000005)
2-(2-{2-[(1e)-2-(3,4-dimethoxyphenyl)ethenyl]-5-methyl-1,3-oxazol-4-yl}-2-oxoethyl)-5-methyl-n-[(2e)-penta-2,4-dien-1-yl]-1,3-oxazole-4-carboximidic acid
C26H27N3O6 (477.18997620000005)